Wild Alaskan Fish Oil Vitamin K2 by Wiley's Finest — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
50% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size

60 Servings

Other Combinations Product Type

50% Evidence Coverage

Supplement Facts — Evidence Check

Calories

6 Calorie(s)

Total Fat

0.6 Gram(s) (1% DV)

Cholesterol

concentrated Fish Oil

625 mg

📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)

This product: 625mg UL 3000mg

Vitamin D3

50 mcg (250% DV)

📊 3.3× RDA — above typical dose (UL: 0.1 mg) 📚 604 studies (Tier A: 16, B: 251)

RDA 0.015mg This product: 0.05mg UL 0.1mg

Vitamin K2

80 mcg

✅ Within RDA (0.7× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)

RDA 0.12mg This product: 0.08mg

Other Ingredients

concentrated Omega-3 Ethyl Esters Fish Gelatin purified Water Vitamin K2 Vitamin D3 non-GMO Mixed Tocopherols

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Only 1 per day

Recommended Use: As a dietary supplement, take 1 softgel daily with food. Effective when taken alone or as a complement to your calcium & magnesium supplement.

⚠️ Warnings & Precautions

Warning: Do not use if safety seal is broken.

Contains fish: Alaska Pollock (Gadus chalcogrammus).

Keep out of reach of children. Softgels can be a choking hazard.

🧪 Formulation Notes

In one small softgel per day, this unique formula provides your daily need for MenaQ7 Vitamin K2 and Vitamin D3, combined with EPA and DHA Omega-3s. K2 and D3, often missing in today's diets, are most effective when paired with heart-healthy fats such as Omega-3s from Fish Oil.

These nutrients direct your calcium to work for you by strengthening bones and opening arteries. Discover your missing link!

MenaQ7 K2 is formulated with fermented non-GMO soy-free chickpeas.

From an MSC certified sustainable fishery. www.msc.org

500 mg EPA + DHA Omega-3 80 mg MenaQ7 Vit. K2 2000 IU Vit. D3 Per serving 650 mg size

Vitamin K2 MenaQ7 (MK-7) and Vitamin D3 improve your body's ability to use bone-building nutrients, such as proteins and calcium, more effectively

Vitamin K2 MenaQ7 (MK-7), Vitamin D3, and EPA + DHA Omega-3s from Fish Oil work together to support heart and circulatory health.

Does not contain: sugar, gluten, starch, yeast, wheat, dairy, artificial flavors, artificial colors, nuts, shellfish, eggs, peanuts, soy or corn.

Additional Information

Direct your calcium Discover the missing link between bone & heart health

Satisfaction guaranteed

Certified Sustainable Seafood MSC www.msc.org Made in USA

2 month supply!

Slow your decline

Store in a cool, dry place.

NSF Contents Certified

Product Details

DSLD Entry Date 2022-08-23

Product Type Other Combinations

Form Softgel Capsule

Brand Wiley's Finest

DSLD ID 269219

Data Updated 2026-04-11

Research Evidence

332 Research Sources

59 Avg Quality Score

220 Meta Analysis

56 Systematic Review

30 Rct

16 Clinical Trial

3 Guideline

3 Regulatory Source

1 Narrative Review

1 Other

1 Openfda Safety

A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Meta Analysis The Cochrane database of systematic reviews 2014

PubMed DOI Cochrane

A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI

A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI

A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair

Meta Analysis The Cochrane database of systematic reviews 2025

PubMed DOI

A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation

Meta Analysis The Cochrane database of systematic reviews 2018

PubMed DOI

A Antiplatelet agents and anticoagulants for hypertension

Systematic Review The Cochrane database of systematic reviews 2022

PubMed DOI

A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI

A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation